KAT II inhibitors

Compounds of Formula I: wherein X, Y, Z, R1, R2, R3, R4 are as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive deficits associated with schizophrenia and other psychiatric, neurodegenerative and/or neurological disorders in mammal...

Full description

Saved in:
Bibliographic Details
Main Authors DOUNAY AMY BETH, PARIKH VINOD DIPAK, VERHOEST PATRICK ROBERT, MCALLISTER LAURA ANN, RONG SUOBAO
Format Patent
LanguageEnglish
Published 13.01.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Compounds of Formula I: wherein X, Y, Z, R1, R2, R3, R4 are as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive deficits associated with schizophrenia and other psychiatric, neurodegenerative and/or neurological disorders in mammals, including humans.
Bibliography:Application Number: US201314068707